258 related articles for article (PubMed ID: 29043385)
1. Whole-Gland Prostate Cancer Cryoablation with Magnetic Resonance Imaging Guidance: One-Year Follow-Up.
Kinsman KA; White ML; Mynderse LA; Kawashima A; Rampton K; Gorny KR; Atwell TD; Felmlee JP; Callstrom MR; Woodrum DA
Cardiovasc Intervent Radiol; 2018 Feb; 41(2):344-349. PubMed ID: 29043385
[TBL] [Abstract][Full Text] [Related]
2. Magnetic resonance imaging-guided cryoablation of recurrent prostate cancer after radical prostatectomy: initial single institution experience.
Woodrum DA; Kawashima A; Karnes RJ; Davis BJ; Frank I; Engen DE; Gorny KR; Felmlee JP; Callstrom MR; Mynderse LA
Urology; 2013 Oct; 82(4):870-5. PubMed ID: 23910089
[TBL] [Abstract][Full Text] [Related]
3. Single center experience with third-generation cryosurgery for management of organ-confined prostate cancer: critical evaluation of short-term outcomes, complications, and patient quality of life.
Hubosky SG; Fabrizio MD; Schellhammer PF; Barone BB; Tepera CM; Given RW
J Endourol; 2007 Dec; 21(12):1521-31. PubMed ID: 18186694
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous MR-guided cryoablation of prostate cancer: initial experience.
Gangi A; Tsoumakidou G; Abdelli O; Buy X; de Mathelin M; Jacqmin D; Lang H
Eur Radiol; 2012 Aug; 22(8):1829-35. PubMed ID: 22752525
[TBL] [Abstract][Full Text] [Related]
5. Real-time magnetic resonance imaging-guided cryoablation of small renal tumors at 1.5 T.
Ahrar K; Ahrar JU; Javadi S; Pan L; Milton DR; Wood CG; Matin SF; Stafford RJ
Invest Radiol; 2013 Jun; 48(6):437-44. PubMed ID: 23511191
[TBL] [Abstract][Full Text] [Related]
6. Rectal wall saline displacement for improved margin during MRI-guided cryoablation of primary and recurrent prostate cancer.
Lomas DJ; Woodrum DA; McLaren RH; Gorny KR; Felmlee JP; Favazza C; Lu A; Mynderse LA
Abdom Radiol (NY); 2020 Apr; 45(4):1155-1161. PubMed ID: 31359096
[TBL] [Abstract][Full Text] [Related]
7. Does prior surgical interventional therapy for BPH affect the oncological or functional outcomes after primary whole-gland prostate cryoablation for localized prostate cancer?
ElShafei A; DeWitt-Foy M; Calaway A; Fernstrum AJ; Hijaz A; Muncey W; Alfahmy A; Mahran A; Mishra K; Stephen Jones J; Polascik TJ
Prostate Cancer Prostatic Dis; 2021 Jun; 24(2):507-513. PubMed ID: 33483626
[TBL] [Abstract][Full Text] [Related]
8. Percutaneous cryoablation of renal cell carcinoma guided by horizontal open magnetic resonance imaging.
Miki K; Shimomura T; Yamada H; Kishimoto K; Ohishi Y; Harada J; Egawa S
Int J Urol; 2006 Jul; 13(7):880-4. PubMed ID: 16882047
[TBL] [Abstract][Full Text] [Related]
9. Treatment of prostate cancer local recurrence after radical retropubic prostatectomy with 17-gauge interstitial transperineal cryoablation: initial experience.
Siddiqui SA; Mynderse LA; Zincke H; Hoffmann NE; Lobo JR; Wilson TM; Kawashima A; Davis BJ; Blute ML
Urology; 2007 Jul; 70(1):80-5. PubMed ID: 17656213
[TBL] [Abstract][Full Text] [Related]
10. Focal cryosurgical ablation of the prostate: a single institute's perspective.
Hale Z; Miyake M; Palacios DA; Rosser CJ
BMC Urol; 2013 Jan; 13():2. PubMed ID: 23311921
[TBL] [Abstract][Full Text] [Related]
11. Percutaneous MR-guided focal cryoablation for recurrent prostate cancer following radiation therapy: retrospective analysis of iceball margins and outcomes.
Overduin CG; Jenniskens SFM; Sedelaar JPM; Bomers JGR; Fütterer JJ
Eur Radiol; 2017 Nov; 27(11):4828-4836. PubMed ID: 28409355
[TBL] [Abstract][Full Text] [Related]
12. Percutaneous MR-guided whole-gland prostate cancer cryoablation: safety considerations and oncologic results in 30 consecutive patients.
De Marini P; Cazzato RL; Garnon J; Tricard T; Koch G; Tsoumakidou G; Ramamurthy N; Lang H; Gangi A
Br J Radiol; 2019 May; 92(1097):20180965. PubMed ID: 30845821
[TBL] [Abstract][Full Text] [Related]
13. MR imaging-guided focal cryoablation in patients with recurrent prostate cancer.
Bomers JG; Yakar D; Overduin CG; Sedelaar JP; Vergunst H; Barentsz JO; de Lange F; Fütterer JJ
Radiology; 2013 Aug; 268(2):451-60. PubMed ID: 23525206
[TBL] [Abstract][Full Text] [Related]
14. Salvage focal prostate cryoablation for locally recurrent prostate cancer after radiotherapy: initial results from the cryo on-line data registry.
Li YH; Elshafei A; Agarwal G; Ruckle H; Powsang J; Jones JS
Prostate; 2015 Jan; 75(1):1-7. PubMed ID: 25283814
[TBL] [Abstract][Full Text] [Related]
15. Five-Year Biochemical Progression-Free Survival Following Salvage Whole-Gland Prostate Cryoablation: Defining Success with Nadir Prostate-Specific Antigen.
Kovac E; ElShafei A; Tay KJ; Mendez M; Polascik TJ; Jones JS
J Endourol; 2016 Jun; 30(6):624-31. PubMed ID: 26915721
[TBL] [Abstract][Full Text] [Related]
16. Early oncological control following partial gland cryo-ablation: a prospective experience specifying reflex MRI guided biopsy of the ablation zone.
Wysock JS; Becher E; Gogaj R; Velazquez N; Lepor H
Prostate Cancer Prostatic Dis; 2021 Mar; 24(1):114-119. PubMed ID: 32636487
[TBL] [Abstract][Full Text] [Related]
17. Use of MRI-Guided Biopsy for Selection and Follow-up of Men Undergoing Hemi-gland Cryoablation of Prostate Cancer.
Zhou SR; Simopoulos DN; Jayadevan R; Felker ER; Delfin MK; Barsa DE; Kwan L; Marks LS
Urology; 2019 Apr; 126():158-164. PubMed ID: 30659903
[TBL] [Abstract][Full Text] [Related]
18. Predictors of prostate-specific antigen biochemical recurrence in patients undergoing primary whole-gland prostate cryoablation.
Liu YY; Chiang PH; Chuang YC; Lee WC; Cheng YT; Wang HJ
Ann Surg Oncol; 2015 May; 22(5):1612-7. PubMed ID: 25287436
[TBL] [Abstract][Full Text] [Related]
19. Oncological and functional outcomes of men undergoing primary whole gland cryoablation of the prostate: A 20-year experience.
Tan WP; Kotamarti S; Chen E; Mahle R; Arcot R; Chang A; Ayala A; Michael Z; Seguier D; Polascik TJ
Cancer; 2022 Nov; 128(21):3824-3830. PubMed ID: 36107496
[TBL] [Abstract][Full Text] [Related]
20. Focal prostate cryoablation: initial results show cancer control and potency preservation.
Bahn DK; Silverman P; Lee F; Badalament R; Bahn ED; Rewcastle JC
J Endourol; 2006 Sep; 20(9):688-92. PubMed ID: 16999628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
